anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
Matinas BioPharma · pitchdeck

Matinas BioPharma | Investor Presentation Deck | 31 slides

31 pages · 4 arc beats · 2 loops

Pitchdeck Download JSON
Unlock

Matinas BioPharma | Investor Presentation Deck | 31 slides

Matinas BioPharma · 2023-11
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON
Narrative range 7 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 1 slides 100% 1/1 slides 100% 1/1 slides · 9 hits
— 0/1 slides
100% 1/1 slides 100% 1/1 slides 100% 1/1 slides 100% 1/1 slides Solution 1 slides 100% 1/1 slides 100% 1/1 slides · 4 hits
— 0/1 slides
100% 1/1 slides 100% 1/1 slides 100% 1/1 slides 100% 1/1 slides Product 4 slides 100% 4/4 slides 100% 4/4 slides · 16 hits
— 0/4 slides
50% 2/4 slides 25% 1/4 slides 100% 4/4 slides
— 0/4 slides
Team 1 slides 100% 1/1 slides 100% 1/1 slides · 10 hits
— 0/1 slides
100% 1/1 slides
— 0/1 slides
100% 1/1 slides
— 0/1 slides

Slide inventory

31
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detail
02
other
Open slide detail
03
The slide uses a process-flow structure to connect the technology platform (LNCs) to a lead asset (MAT2203) and future pipeline expansion.present_solution
Open slide detail
04
The slide uses a Gantt-style visualization to show the development stage of various programs.show_traction
Open slide detail
05
The slide uses a combination of molecular diagrams and bulleted lists to explain the mechanism and benefits of the LNC technology.present_solution
Open slide detailBeat · Product
06
Technical scientific slide detailing the mechanism of action for a drug delivery platform.present_solution
Open slide detailBeat · Product
07
The LNC column is highlighted in light yellow to emphasize the company's proprietary technology.compare_peers
Open slide detailBeat · Product
08
transition
Open slide detailBeat · Product
09
Uses authority-citation to establish urgency and market relevance.argue_timing
Open slide detailBeat · ProblemLoop · Cost Of Inaction
10
Uses a 'Before-After-Bridge' style logic (Characteristics - Limitations = Unlocked Potential).present_solution
Open slide detailBeat · SolutionLoop · Cost Of Inaction
11
The slide uses a process flow diagram to map clinical outcomes to specific data points.show_traction
Open slide detailLoop · Cost Of Inaction
12
This is a credibility-building slide showcasing academic validation of the company's technology.show_traction
Open slide detailLoop · Cost Of Inaction
13
The slide uses a human silhouette as a central anchor to map specific clinical indications to anatomical locations.present_solution
Open slide detailLoop · Cost Of Inaction
14
Focuses on patients who failed or could not tolerate standard azole or IV Amphotericin B therapies.show_traction
Open slide detailLoop · Cost Of Inaction
15
The slide uses a timeline diagram combined with two line charts to demonstrate clinical efficacy and safety.illustrate_case
Open slide detailLoop · Cost Of Inaction
16
The slide highlights both the clinical urgency and the commercial orphan disease opportunity.frame_problem
Open slide detailLoop · Cost Of Inaction
17
plan_implementation
Open slide detail
18
The slide uses a process flow diagram to illustrate the clinical trial methodology.plan_implementation
Open slide detail
19
Uses a combination of an equation-style value proposition and a chevron-based process/timeline diagram.present_solution
Open slide detail
20
transition
Open slide detail
21
The slide uses a matrix-like structure to map disease areas (Infection, Inflammation, Oncology) to specific animal models and clinical indications.show_traction
Open slide detail
22
Data presented as a multi-panel chart comparing Uninfected, Infected Untreated, SQ Remdesivir, and Oral LNC-Remdesivir groups.show_traction
Open slide detail
23
The chart demonstrates high uptake efficiency of LNC-formulated oligos over time across different cell types.show_traction
Open slide detail
24
The chart shows dose-dependent inhibition; LNC formulations consistently outperform Taxol.show_traction
Open slide detail
25
The slide demonstrates that oral LNC-docetaxel is as effective as IV docetaxel with no significant side effects.analyze_data
Open slide detail
26
The chart shows a clear dose-response relationship with increasing efficacy of the LNC formulation at 2.5, 5, and 10 nM doses.show_traction
Open slide detail
27
Uses a chevron-based process flow to represent maturity stages.plan_implementation
Open slide detailLoop · Why Now
28
The slide uses a grid-based timeline layout to track multiple workstreams simultaneously.plan_implementation
Open slide detailLoop · Why Now
29
present_solution
Open slide detailLoop · Why Now
30
other
Open slide detailBeat · Team
31
The slide uses a mix of checkmarks for completed milestones and circular arrows for pending ones.summarize
Open slide detail